Cumberland Pharmaceuticals Inc. (CPIX)

Import this data to Google Sheets with:

=jivedata("CPIX","financials")

Full statements spill as a table. For one cell: =jivedata("CPIX","Revenue") or =jivedata("CPIX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Cumberland Pharmaceuticals Inc.

CPIX • CIK 0001087294

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$39,552.507	$37,867.945	$44,521.431	$39,903.572
Investment Income, Interest	$286.854	$334.444	$476.748	$362.465
Insured Event, Gain (Loss)	$346.8	$237.089	$0	$0
Interest Expense	$667.861	$605.508	$495.99	$223.431
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	—	—	$-2,811.235	$-7,202.189
Income Tax Expense (Benefit)	$45.769	$-22.669	$40.256	$36.656
Income (Loss) from Equity Method Investments	—	—	$-13.22	$-159.3
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-6,330.766	$-6,443.715	$-2,864.711	$-10,939.169
Net Income (Loss) Attributable to Noncontrolling Interest	$-51.446	$36.055	$-28.583	$-20.697
Net Income (Loss) Attributable to Parent	$-6,279.32	$-6,479.77	$-2,836.128	$-10,918.472
Cost of Goods and Services Sold	$6,066.611	$6,585.972	$6,667.207	$7,175.382
Selling and Marketing Expense	$18,451.765	$17,023.023	$19,098.153	$19,931.048
Research and Development Expense	$5,834.229	$4,816.206	$5,566.498	$4,341.03
General and Administrative Expense	$10,651.915	$11,126.901	$11,946.909	$11,479.959
Amortization of Intangible Assets	$8,102.648	$4,748.252	$4,034.657	$2,036.995
Costs and Expenses	$49,107.168	$44,300.354	$47,313.424	$31,730.614
Operating Income (Loss)	$-9,554.661	$-6,432.409	$-2,791.993	$-9,429.293
Weighted Average Number of Shares Outstanding, Basic	14,298,774	14,060,272	14,854,619	14,873,978
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	—	$-6,443.715	$-2,864.711	$-3,221.656
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	452,224	611,353	891,381	805,198

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$18,321.624	$17,964.184	$11,444.693	$3,862.402
Accounts Receivable, after Allowance for Credit Loss, Current	$9,758.176	$11,701.466	$16,944.78	$13,419.594
Inventory, Noncurrent	$12,804.529	$11,005.499	$9,253.09	$40.879
Inventory, Net	$4,609.362	$3,999.995	$6,225.518	$29.935
Property, Plant and Equipment, Net	$367.903	$277.365	$264.724	$248.808
Prepaid Expense and Other Assets, Current	$3,025.248	$2,786.513	$2,445.276	$675.993
Finite-Lived Intangible Assets, Net	$22,607.918	$17,973.449	$14,027.921	$43.804
Assets, Current	$35,714.41	$36,452.158	$37,060.267	$33,641.145
Goodwill	$914	$914	$914	$914
Operating Lease, Right-of-Use Asset	$6,674.394	$6,176.923	$8,343.832	$7,281.28
Investments	—	—	$3,986.78	$3,840.7
Other Assets, Noncurrent	$2,692.921	$2,784.016	$2,973.378	$3,171.623
Assets	$81,776.075	$75,583.41	$76,823.992	$62,879.694
Long-term Line of Credit, Noncurrent	$12,784.144	$10,176.17	$5,240.733	$0
Operating Lease, Liability, Noncurrent	$5,296.247	$4,939.739	$4,471.965	$4,211.168
Other Liabilities, Noncurrent	$6,453.566	$6,299.795	$5,822.153	$3,981.224
Liabilities	$52,516.206	$53,037.433	$52,279.77	$45,773.246
Accounts Payable, Current	$14,037.629	$13,914.266	$18,567.546	$19,554.251
Operating Lease, Liability, Current	$348.092	$356.508	$467.774	$503.016
Long-term Debt, Current Maturities	—	$5,100	$0	$0
Investment-related Liabilities	—	—	$5,074.504	$4,487.137
Other Liabilities, Current	$13,596.528	$12,250.955	$12,635.095	$2,242.122
Liabilities, Current	$27,982.249	$31,621.729	$36,744.919	$35,193.138
Stockholders' Equity Attributable to Noncontrolling Interest	$-343.572	$-307.517	$-336.1	$-331.565
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$29,259.869	$22,545.977	$24,544.222	$17,106.448
Common Stock, Value, Outstanding	$47,091.602	$46,821.425	$51,684.381	$51,808.088
Retained Earnings (Accumulated Deficit)	$-17,488.161	$-23,967.931	$-26,804.059	$-34,370.075
Stockholders' Equity Attributable to Parent	$29,603.441	$22,853.494	$24,880.322	$17,438.013
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	14,121,833	13,952,624	14,956,627	14,983,107

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-6,330.766	$-6,443.715	$-2,864.711	$-10,939.169
Net Cash Provided by (Used in) Operating Activities	$6,093.821	$-612.186	$4,932.522	$745.969
Depreciation, Depletion and Amortization	$4,935.954	$4,902.56	$4,145.201	$2,151.318
Payments to Acquire Property, Plant, and Equipment	$281.268	$66.461	$97.903	$62.07
Operating Lease, Right-of-Use Asset, Amortization Expense	$834.5	$1,140.738	$1,140.738	$1,051.692
Payments to Acquire Intangible Assets	$171.783	$113.253	$84.402	$59.894
Gain (Loss) on Investments	—	—	$-13.22	$-13.22
Payments to Acquire Businesses, Gross	$0	—	$2,477.192	$2,477.192
Gain (Loss) on Disposition of Assets	$-20.256	$-2.691	$0	$0
Payments to Acquire Other Investments	—	—	$2,000	$2,000
Share-based Payment Arrangement, Noncash Expense	$365.04	$301.895	$408.32	$438.13
Payment to Acquire Life Insurance Policy, Investing Activities	—	—	$47	$89.018
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-1,253.84	$-1,460.804	$46.569	$-227.372
Proceeds from Life Insurance Policy	$347.356	$237.556	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-105.695	$57.842	$-4,706.497	$-5,751.766
Amortization of Debt Issuance Costs	$15.523	$28.313	$23.185	$22.996
Other Nonoperating Gains (Losses)	$346.8	$237.089	$0	$0
Proceeds from (Repayments of) Lines of Credit	$31,475	$38,488.92	$0	$0
Repayments of Notes Payable	$34,890.856	$35,996.894	$10,035.437	$5,240.733
Payments for Repurchase of Common Stock	$740.533	$579.049	$263.478	$71.44
Payment for Contingent Consideration Liability, Financing Activities	$3,268.083	$1,716.073	$1,712.935	$1,904.103
Net Cash Provided by (Used in) Financing Activities	$-7,424.472	$196.904	$-6,745.516	$-7,219.082
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-1,436.346	$-357.44	$-6,519.491	$-12,224.879
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$18,321.624	$17,964.184	$11,444.693	$7,343.525
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$1,158.367	$128.039	$438.311	$438.311
Increase (Decrease) in Accounts Receivable	$-3,404.949	$1,943.29	$5,243.314	$3,102.683
Increase (Decrease) in Inventories	$23.143	$-2,408.397	$-2,242.616	$-424.42
Increase (Decrease) in Other Operating Assets	$-65.684	$-189.112	$231.829	$914.793
IncreaseDecreaseInOperatingLeaseLiability	$-1,405.363	$1,784.089	$-836.1	$-847.86
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$3,724.174	$-991.359	$6,709.196	$8,836.351
Increase (Decrease) in Other Noncurrent Liabilities	$-1,131.453	$-153.771	$-477.642	$-124.664
Interest Paid, Excluding Capitalized Interest, Operating Activities	$647.137	$569.23	$441.677	$441.677
Income Taxes Paid, Net	$108.823	$15	$-3.525	$-3.525

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CPIX","financials")

Full statements spill as a table. For one cell: =jivedata("CPIX","Revenue") or =jivedata("CPIX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.